Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tegoprazan-containing Sequential for H. Pylori
Sponsor: Seoul National University Bundang Hospital
Summary
As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy
Official title: Efficacy of Tegoprazan-containing Sequential Therapy Compared to Proton Pump Inhibitor-based Eradication in South Korea, a Region With High Antimicrobial Resistance: A Prospective Randomized Single Tertiary Center Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2021-02-01
Completion Date
2024-12-12
Last Updated
2024-05-02
Healthy Volunteers
Yes
Conditions
Interventions
Tegoprazan-containing sequential H. pylori eradication therapy
tegoprazan was administered, instead propton-pump inhibitor, as acid blockade in H. pylori eradication sequential therapy
Esomeprazole-containing sequential H. pylori eradication therapy
Esomeprazole was administered as acid blockade in H. pylori eradication sequential therapy (conventional acid blockade method for sequential eradication therapy)
Locations (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea